Clinical and economic impact of a one-year treatment with omalizumab in patients with severe allergic asthma within a drug programme in Poland

Overview of attention for article published in BMC Pulmonary Medicine, March 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 13,227 followers.

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.